J 2020

Copper Concentrations in Breast Cancer: A Systematic Review and Meta-Analysis

JOUYBARI, L., F. KIANI, F. ISLAMI, A. SANAGOO, F. SAYEHMIRI et. al.

Základní údaje

Originální název

Copper Concentrations in Breast Cancer: A Systematic Review and Meta-Analysis

Autoři

JOUYBARI, L., F. KIANI, F. ISLAMI, A. SANAGOO (garant), F. SAYEHMIRI, B. HOSNEDLOVA, M. D. DOSA, René KIZEK (203 Česká republika, domácí), S. CHIRUMBOLO a G. BJORKLUND

Vydání

Current Medicinal Chemistry, Sharjah, Betham Science Publishers, 2020, 0929-8673

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30104 Pharmacology and pharmacy

Stát vydavatele

Spojené arabské emiráty

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 4.530

Kód RIV

RIV/00216224:14160/20:00118452

Organizační jednotka

Farmaceutická fakulta

UT WoS

000589111000005

Klíčová slova anglicky

Copper; breast cancer; women; blood; breast tissue; hair analysis

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 25. 3. 2021 18:00, Mgr. Hana Hurtová

Anotace

V originále

Breast cancer is the most common neoplasm, comprising 16% of all women's cancers worldwide. Research of Copper (Cu) concentrations in various body specimens have suggested an association between Cu levels and breast cancer risks. This systematic review and meta-analysis summarize the results of published studies and examine this association. We searched the databases PubMed, Scopus, Web of Science, and Google Scholar and the reference lists of relevant publications. The Standardized Mean Differences (SMDs) between Cu levels in cancer cases and controls and corresponding Confidence Intervals (CIs), as well as I-2 statistics, were calculated to examine heterogeneity. Following the specimens used in the original studies, the Cu concentrations were examined in three subgroups: serum or plasma, breast tissue, and scalp hair. We identified 1711 relevant studies published from 1984 to 2017. There was no statistically significant difference between breast cancer cases and controls for Cu levels assayed in any studied specimen; the SMD (95% CI) was -0.01 (-1.06 - 1.03; P = 0.98) for blood or serum, 0.51 (-0.70 - 1.73; P = 0.41) for breast tissue, and -0.88 (-3.42 - 1.65; P = 0.50) for hair samples. However, the heterogeneity between studies was very high (P < 0.001) in all subgroups. We did not find evidence for publication bias (P = 0.91). The results of this meta-analysis do not support an association between Cu levels and breast cancer. However, due to high heterogeneity in the results of original studies, this conclusion needs to be confirmed by well-designed prospective studies.